Company Presentation • 06 Nov 2024 21:30
Company Presentation • 08 Aug 2024 20:30
Company Presentation • 09 May 2024 20:30
Company Presentation • 28 Feb 2024 21:30
Company Presentation • 11 Jan 2024 05:00
ENTITY
Amicus Therapeutics (FOLD US)
Amicus Therapeutics (FOLD US)
5
Analysis
Health Care • United States
Amicus Therapeutics, Inc. is a biopharmaceutical company that develops orally-administered, small molecule drugs to treat human genetic diseases. The drugs, called pharmacological chaperones, are being developed to treat Fabray, Gaucher, and Pompe disease.
more
x